Leo Ehrlich is CEO and Chairman of Innovation Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of IPIX, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2020, when has been sold 7,835,002 shares (Class A Common Stock) at a price of $0.21 per share, resulting in proceeds of $1,645,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

LEO EHRLICH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2020
SELL
Payment of exercise price or tax liability
$1,645,350 $0.21 p/Share
7,835,002 Reduced 100.0%
0 Class A Common Stock
Feb 23 2020
BUY
Grant, award, or other acquisition
-
500,000 Added 6.0%
7,835,002 Class A Common Stock
LE

Leo Ehrlich

CEO and Chairman
Wakefield, MA

Track Institutional and Insider Activities on IPIX

Follow Innovation Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPIX shares.

Notify only if

Insider Trading

Get notified when an Innovation Pharmaceuticals Inc. insider buys or sells IPIX shares.

Notify only if

News

Receive news related to Innovation Pharmaceuticals Inc.

Track Activities on IPIX